Payer+Provider's Health System Review
May 17, 2021
Some worry the departure of Anne Schuchat, a longtime stabilizing force, would undermine still-flagging morale.
The vaccine candidate “triggered strong immune response amongst adults of all age groups,” the companies said in a joint statement.
May 16, 2021
Walensky says science, not pressure, drove the agency’s change on mask-wearing.
May 9, 2021
Critics say the administration has taken a piecemeal approach to the worsening international crisis, when a far-reaching plan is needed.
May 7, 2021
Elinore McCance-Katz spoke out against coronavirus response, saying risks had been exaggerated.
May 5, 2021
Dozens of developing countries back the proposal, arguing it will allow them to rapidly produce their own generic vaccines, rather than wait months or years for sufficient doses.
May 3, 2021
The White House and public health experts are studying the Americans who went from “no” to “yes.”
April 30, 2021
A proposal to waive drugmakers’ patents to enable developing countries to make generic vaccines wins some backers in the Biden administration.
April 20, 2021
The pause on administering Johnson & Johnson vaccine appears to have little effect, but other messages continue to alienate GOP holdouts.
April 19, 2021
Bureaucratic infighting put evacuees, officials and U.S. communities at risk of coronavirus, a report says.